FDA's Vinay Prasad, controversial CBER chief, to depart

https://misryoum.com/us/trending/fdas-vinay-prasad-controversial-cber-chief-to-depart/

WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave the FDA at the end of...

#FDAs #Vinay #Prasad #controversial #CBER #chief #depart #US_News_Hub #misryoum_com

FDA's Vinay Prasad, controversial CBER chief, to depart

WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the

US News Hub
@STAT's Lizzy Lawrence takes a look at the lead up to Vinay Prasad's abrupt departure from #FDA. The now former #CBER head "wasn’t able to outrun his firebrand persona," she writes.
https://www.statnews.com/2025/07/30/vinay-prasad-analysis-departure-fda-cber-director-top-vaccine-official/
Inside the fall of Vinay Prasad at the FDA

Prasad's departure followed a campaign by a right-wing activist and a controversy over a rare disease drug.

STAT

#FYI #USA #MicrobeTV #TWiV #ThisWeekInVirology #DanielGriffin #VincentRacaniello #infectiousdiseases #vaccinate #vaccines #covid19 #covid #sarscov2 #CBER

"WiV reviews new CBER chief at FDA, ending of Gates Foundation in 2045, gain of function executive order, origins of bat viruses ancestral to SARS-CoV and SARS-CoV-2, and single dose Sudan virus replicon vaccine protects guinea pigs from disease."

https://www.youtube.com/watch?v=tbMoqTH4wt4

TWiV 1217: Alternative vax and pandemic origins

YouTube